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Abstract
Lysozymes and hexosaminidases are ubiquitous hydrolases in bacteria and eukaryotes. In phagocytic lower eukaryotes and
professional phagocytes from higher eukaryotes, they are involved in the degradation of ingested bacteria in phagosomes.
In Entamoeba histolytica, which is the intestinal protozoan parasite that causes amoebiasis, phagocytosis plays a pivotal role
in the nutrient acquisition and the evasion from the host defense systems. While the content of phagosomes and
biochemical and physiological roles of the major phagosomal proteins have been established in E. histolytica, the
mechanisms of trafficking of these phagosomal proteins, in general, remain largely unknown. In this study, we identified
and characterized for the first time the putative receptor/carrier involved in the transport of the above-mentioned
hydrolases to phagosomes. We have shown that the receptor, designated as cysteine protease binding protein family 8
(CPBF8), is localized in lysosomes and mediates transport of lysozymes and b-hexosaminidase a-subunit to phagosomes
when the amoeba ingests mammalian cells or Gram-positive bacillus Clostridium perfringens. We have also shown that the
binding of CPBF8 to the cargos is mediated by the serine-rich domain, more specifically three serine residues of the domain,
which likely contains trifluoroacetic acid-sensitive O-phosphodiester-linked glycan modifications, of CPBF8. We further
showed that the repression of CPBF8 by gene silencing reduced the lysozyme and b-hexosaminidase activity in
phagosomes and delayed the degradation of C. perfringens. Repression of CPBF8 also resulted in decrease in the cytopathy
against the mammalian cells, suggesting that CPBF8 may also be involved in, besides the degradation of ingested bacteria,
the pathogenesis against the mammalian hosts. This work represents the first case of the identification of a transport
receptor of hydrolytic enzymes responsible for the degradation of microorganisms in phagosomes.
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Introduction
Lysozymes (EC 3.2.1.17) are the antibacterial protein that has
an ability to damage the cell wall of bacteria [1]. The enzyme acts
by catalyzing the hydrolysis of 1,4-beta-linkages between N-
acetylmuramic acid and N-acetyl-D-glucosamine in peptidogly-
cans and between the N-acetyl-D-glucosamine residues in
chitodextrins. While biochemical [2], functional [3], and structural
[4] features of lysozymes have been well established, the
mechanisms for intracellular trafficking and secretion remain
poorly characterized except for the report that showed that
condroitin sulfate is involved in lysosomal targeting of lysozymes
[5]. Hexosaminidase (EC 3.2.1.52) is involved in the hydrolysis of
terminal N-acetyl-D-hexosamine residues in hexosaminides. Three
dimeric isozymes of b-hexosaminidase are formed by the
combination of a and b subunits, encoded by HEXA and HEXB
genes, respectively. b-Hexosaminidase and the cofactor GM2
activator protein catalyze the degradation of the GM2 gangliosides
containing terminal N-acetyl hexosamines [6]. Mutations in
HEXA gene decrease the hydrolysis of GM2 gangliosides, which
is the main cause of Tay-Sachs disease, whereas mutations in
HEXB gene results in Sandhoff disease [7]. The trafficking
mechanism of b-hexosaminidase via mannose-6-phosphate recep-
tor has been well studied in mouse lymphoma and myeloma cell
[8–10]. However, the mechanisms of trafficking of b-hexosamin-
idase in eukaryotes besides mammals remain to be discovered.
Lysozyme and b-hexosaminidase are abundant components
found in phagosomes from Entamoeba histolytica [11,12], which is
the anaerobic or microaerophilic protozoan parasite, causing
amebic dysentery and amebic liver abscesses in an estimated 10
million cases annually [13]. However, the role and intracellular
trafficking of these enzymes remain unknown. Phagocytosis and
phagosome biogenesis seems to play a pivotal role in pathogenesis
in E. histolytica [14]. E. histolytica is capable of internalizing
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ingest microorganisms in the large intestine [15,16], and host cells
including non-immune cells [17], and immune cells [18] during
tissue invasion. It has been well-established that in vitro and in
vivo virulence correlates well with the ability of phagocytosis
[14,19,20]. Furthermore, phagosomes contain a panel of proteins
that were shown to be crucial in pathogenesis such as cysteine
proteases (CPs) [21], amoeba pores [22], and galactose/N-
acetylgalactosamine-specific lectin [23,24], proteins involved in
cytoskeletal reorganization [25,26], vesicular trafficking [27–29],
and signal transduction [30,31]. Therefore, understanding the
molecular mechanisms of phagocytosis and phagosome biogenesis
as well as the role and trafficking of individual phagosomal
proteins in phagosomes, should help to understand underlying
links between phagocytosis and pathogenicity.
Recently, the proteins and mechanisms involved in phagocytosis
have been demonstrated. For instance, the surface Ca
2+-binding
kinase (C2PK) has shown to be involved in the initiation of
phagocytosis [31]. The antisense inhibition of C2PK caused
inhibition of the initiation of erythrophagocytosis. It has also been
shown that surface transmembrane kinase (TMK96) and p21-
activated kinase (PAK) play an important role in phagocytosis of
human erythrocytes [32,33]. The unconventional myosin, myosin
IB, was shown to be involved in cytoskeleton rearrangement
during phagocytosis [25,26]. Furthermore, phosphatidylinositides
also play critical roles during phagocytosis [34,35]. Our previous
proteomic studies, where 159 proteins were identified from
purified phagosomes [11,12], also suggested a direct link between
phagosome biogenesis and pathogenesis, as phagosomes contained
a panel of proteins that were shown to be crucial in pathogenesis
described above. Furthermore, the proteins that are implicated for
degradation of phagocytosed bacteria, e.g. amoebapores [22],
lysozymes, and b-hexosaminidase, as well as other hydrolytic
enzymes such as amylase and ribonuclease were also demonstrated
in phagosomes. While both the constituents of phagosomes and
the kinetics of their recruitment are known, very little is known on
how these proteins are transported to phagosomes. Recently, we
discovered a putative transmembrane receptor for cysteine
proteases from E. histolytica, which preferentially binds to CP5
(Nakada-Tsukui K, et al., unpublished data), which is directly
implicated in the pathogenesis [36–38]. The E. histolytica genome
contained a total of 11 members showing significant mutual
identity and structural conservation to the transmembrane
cysteine protease receptor: the signal peptide at the amino
terminus, a single transmembrane domain close to the carboxyl
terminus, and the YxxW motif at the carboxyl terminus. This
family of proteins was designated as cysteine protease binding
family proteins 1–11 (CPBF1-11). In the present study, we
characterized one of the most highly expressed CPBF genes
among the family, CPBF8. We showed that CPBF8 localizes to
phagosomes during phagocytosis, while it is distributed to the
acidic compartment in steady state. Affinity immunoprecipitation
followed by LC-MS/MS analysis showed that CPBF8 specifically
bound to lysozymes and b-hexosaminidase a-subunit. Repression
of CPBF8 by gene silencing reduced lysozyme and b-hexosamin-




We examined the localization of CPBF8 during phagocytosis of
CHO cells. Trophozoites of CPBF8-HA-expressing strain were
incubated with CellTracker-loaded CHO cells for 10 to 60 min to
allow ingestion of CHO cells. Immunofluorescence assay using
anti-HA antibody showed that CPBF8 was localized to phago-
somes containing CHO cells at all time points (10, 30, and
60 mins) (Figure 1A). CPBF8 remained associated with phago-
somes in the course of phagocytosis: the percentage of colocaliza-
tion did not significantly changed (84, 92 and 82% at 10, 30, and
60 min, respectively). Immunofluorescence image of the amoeba
undergoing engulfment revealed that CPBF8 localized to the
basolateral portion of a phagosome, and excluded from the tunnel-
like structure connecting a phagosome and the CHO cell being
aspirated [35].
As immunofluorescence assay showed that CPBF8 was also
distributed to a large number of vesicles and vacuoles under
quiescent (i.e., non-phagocytic) conditions, we examined the
nature of these compartments. CPBF8-HA was associated with
the acidic organelles labeled with membrane-diffusible Lyso-
Tracker under steady-state conditions (60% of LysoTracker-
positive vesicles/vacuoles was positive for CPBF8) (Figure 1B).
CPBF8 colocalized nicely with a vacuolar membrane protein,
pyridine nucleotide transhydrogenase, EhPNT, which converts
NADPH and NADH using the proton gradient across the
membrane [39] (Figure 1C). It has been shown that EhPNT is
localized to the acidic compartment in steady state and
transported to phagosomes upon phagocytosis [40].
CPBF8 binds to b-hexosaminidase a-subunit and
lysozymes
To identify potential cargo proteins that CPBF8 binds and
carries to phagosomes, we immunoprecipitated proteins that bind
to CPBF8, from the lysates of the transformant where HA-tagged
CPBF8 was ectopically expressed (Figure 2). Silver stained SDS-
PAGE gel revealed three major bands of about .120, 60, and
20 kDa (bands C, E, and F) and three minor bands of about .300,
.200, and 75 kDa (bands A, B, and D) exclusively found in the
immunoprecipitated sample from CPBF8-HA strain, but not from
HA control strain. These bands were excised and subjected to LC-
MS/MS analysis (Table 1 and Table S1). Smeary band C, which
showed an apparent molecular mass of ,130 kDa on SDS-PAGE
was identified as CPBF8 itself; the apparent size was larger than
the predicted size (99.3 kDa), suggestive of post-translational
modifications or aberrant structure (see below). Band E was
identified as b-hexosaminidase a-subunit (XP_657529; EHI_
148130) with 19.7% coverage. Band F was identified as a mixture
Author Summary
Phagocytosis is the cellular process of engulfing solid
particles to form an internal phagosome in protozoa,
algae, and professional phagocytes of multicellular eu-
karyotic organisms. In phagocytic protozoa, phagocytosis
is involved in the acquisition of nutrients, and the evasion
from the host immune system and inflammation. While
hydrolytic enzymes that are essential for the efficient and
regulated degradation of phagocytosed particles, such as
bacteria, fungi, and eukaryotic organisms, have been
characterized, the mechanisms of the transport of these
proteins are poorly understood. In the present study, we
have demonstrated, for the first time, the molecular
mechanisms of how the digestive enzymes are transported
to phagosomes. Understanding of such mechanisms of the
transport of phagosomal proteins at the molecular level
may lead to the identification of a novel target for the
development of new preventive measures against parasitic
infections caused by phagocytic protozoa.
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PLoS Pathogens | www.plospathogens.org 2 February 2012 | Volume 8 | Issue 2 | e1002539Figure 1. Localization of CPBF8 in E. histolytica. (A) Phagosome localization of CPBF8. Amoebae were incubated with Cell Tracker Blue-stained
CHO cells (blue) for 10 (top row) or 60 minutes (bottom row), fixed, and reacted with anti-HA antibody (green). Bar,1 0mm. (B) Lysosomes localization
of CPBF8. Amoebae were labeled with LysoTracker Red (red) and subjected to immunofluorescence assay with anti-HA antibody (green). Bar, 10 mm.
(C) Colocalization of EhPNT and CPBF8. The cells were fixed, and reacted with anti-EhPNT (red) and anti-HA antibody (green). Bar, 10 mm.
doi:10.1371/journal.ppat.1002539.g001
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(XP_656933; EHI_096570) with 22.7 and 30.2% coverage,
respectively. Lysozyme 1 and 2 were previously demonstrated by
our previous phagosome proteome analysis [11,12]. Bands A, B,
and D mostly corresponded to CPBF8 (Table S1). These data
clearly indicate that b-hexosaminidase a-subunit and lysozymes
are predominant proteins that bind CPBF8. b-hexosaminidase a-
subunit was not previously detected by phagosome proteomics,
whereas its b-subunit was detected.
Repression of CPBF8 by gene silencing decreases b-
hexosaminidase and lysozyme activity
To further demonstrate the role of CPBF8, we created a strain
in which CPBF8 expession was repressed by long term
transcriptional gene silencing [41] (‘‘CPBF8gs strain’’). Gene
silencing is mediated by nuclear localized antisense small RNAs
with 59-polyphosphate termini [42], and observed only in G3 and
its derived strains, in which amoebapore genes have been
repressed. RT-PCR analysis showed that the mRNA level of
CPBF8 gene in CPBF8gs strain was specifically reduced to the
undetectable level (Figure 3A). DNA microarray analysis further
verified that CPBF8 transcript was reduced by 326 fold, while the
expression of other CPBF genes remained unchanged (Figure 3B).
In in vitro cultivation CPBF8gs strain did not show any defect in
growth compared to control pSAP2-Gunma-transfected strain
(Supplemental information Figure S1). The doubling times of
control and CPBF8gs strains were comparable (20.9 and 20.6 h,
respectively). Thus, the defects in protein transport and the
decrease in cytopathy against mammalian cells and bacteria
digestion, described below, are not likely attributable to poor
proliferation (growth) of CPBF8gs strain.
We examined b-hexosaminidase and lysozyme activities in
CPBF8gs and control strains using a synthetic N-acetylglucosa-
mine-related substrate (4-methylumbelliferyl-2-acetamido-2-de-
oxy-b-D-glucopyranoside, MUG) and its sulfo derivative (MUGS)
(for b-hexosaminidase), and Bodipy-conjugated Micrococcus lyso-
deikticus cell wall (for lysozymes). The enzyme activity toward
MUGS in the whole cells of CPBF8gs strain (0.045 U/g)
decreased by 81%, compared to control (0.234) (Figure 4A),
whereas that toward MUG reduced by 32% (44.4 and 30.4 U/g
in control and CPBF8gs strain, respectively) (Figure 4B). The
activity toward MUGS or MUG is known to attributable to b-
hexosaminidase activity of a homodimer of a-subunit, or that of
both a homodimer of b-subunit and a a/b-subunit heterodimer
[43]. The b-hexosaminidase activity toward MUGS and MUG,
secreted to the culture medium, also decreased by 37 and 43% in
CPBF8gs strain, respectively. The lysozyme activities in the whole
cell lysates of CPBF8gs strain appear to be slightly decreased
(4.3%), while the amylase activity remained unchanged (Figures 4,
C and D). One should know that the degree of lysozyme secretion
was much higher than that of b-hexosaminidase. b-Hexosamin-
idase activity detected in the culture supernatant was almost
negligible (Figure 4A and B), and may be attributable to lysed cells.
In addition, lysozyme activity detected in the whole lysates and the
culture supernatant appear to be attributable to proteins other
than lysozyme 1 and 2 because the lysozyme activity in the isolated
phagosomes and the amount of lysozyme 2 in the whole cells and
Figure 2. Isolation and identification of CPBF8-binding pro-
teins. Lysates of CPBF8-HA and control (‘‘HA’’) transformants were
mixed with anti-HA-antibody-conjugated agarose, washed, and eluted
with HA peptide. Immunoprecipitated samples were separated on SDS-
PAGE and silver stained. Apparent molecular weight of standards (kDa)
are indicated on the left. Six bands excised for protein identification are
marked (A–F).
doi:10.1371/journal.ppat.1002539.g002
Table 1. Identification of CPBF-binding proteins by LC-MS/MS analysis.
Size of excised
band (kDa) (name)
ID number of identified




100–150 (C) EHI_059830 (XM_647807) 35.1 CPBF8 99.3
60 (E) EHI_148130 (XM_652437) 19.7 b-hexosaminidase a-subunit 61.0
20 (F) EHI_199110 (XM_648202) 22.7 lysozyme 23.5
EHI_096570 (XM_651841) 30.2 lysozyme 23.4
1coverage based on the peptides over 95% probability.
doi:10.1371/journal.ppat.1002539.t001
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greatly decreased (see below).
Phagosome targeting of b-hexosaminidase and
lysozymes is inhibited by the repression of CPBF8
In order to further investigate whether CPBF8 is involved in
trafficking of b-hexosaminidase a-subunit and lysozymes to
phagosomes, we compared these activities in phagosomes isolated
and purified, as previously described [12], from CPBF8gs and
control strains (Figure 4E). We observed that b-hexosaminidase a-
subunit and lysozyme activities in purified phagosomes decreased
by 90 and 96%, respectively, in CPBF8gs, compared to the control
strain, while the amylase activity in phagosomes remained
unchanged. Immuno blot analysis also confirmed the results of
the activity assays, and indicated that lysozyme 2 is not transported
to phagosomes in CPBF8gs strain (Figure 4F).
Repression of CPBF8 inhibits digestion of ingested
bacteria
To understand biological significance of CPBF8, we examined
phagocytosis and degradation of a representative Gram-positive
bacillus Clostridium perfringens in CPBF8gs strain. We microscopi-
cally monitored a course of degradation of ingested C. perfringens
(Figure 5A). Intact and rod-shaped C. perfringens becomes rounded
in phagosomes when it is permeabilized and degraded. After 4 h
co-incubation of SYTO-59-prestained bacteria with the amoebae,
both the rod-shaped and rounded bacteria were counted
(Figure 5B). While the total number of bacteria ingested were
comparable in the control and CPBF8gs strains (12.263.8 and
9.163.8 per amoeba, respectively), the number of rounded
bacteria (0.360.4 per amoeba) dramatically decreased in
CPBF8gs compared to the control (8.164.1 per amoeba), whereas
that of rod-shaped bacteria increased by two fold (8.863.9 and
4.063.2, respectively). These results clearly indicate that degra-
dation of C. perfringens was inhibited by the repression of CPBF8.
Repression of CPBF8 decreases the cytopathic activity
We investigated whether CPBF8 is involved in the cytopathic
effects on monolayers of cultured mammalian cells. The
monolayers of Chinese hamster ovary (CHO) cells were incubated
with the control and CPBF8gs strains for 1–3 h, and destruction of
CHO cells was measured. The cytopathic activity caused by
CPBF8gs strain was lower by 23–29% at all time points compared
to control strain (Figure 5C). The observed cytopathic effect was
partially blocked by 200 mM of the cysteine protease inhibitor E-
64 [44,45]. The cytopathic effect by the control strain was reduced
by 20–22%, whereas that by CPBF8gs was decreased by 41–45%
(Figure 5D). These results support the hypothesis that the decrease
in the cytopathic activity in CPBF8gs was due to the decrease in b-
hexosaminidase a-subunit and lysozymes.
To confirm this hypothesis, we also created the strains where b-
hexosaminidase a-subunit or lysozyme 1 genes was repressed
(HexAgs and Lys1gs strains). These silenced strains showed
reduced cytotoxity to CHO cells compared to the control mock
transformant by 9–18% reduction, as measured at 60 mins of co-
incubation (Supplemental information Figure S2). These data
indicate that secreted (and maybe also intracellular) lysozymes are
involved in CHO cytolysis, and that intracellular b-hexosamini-
dase a-subunit is also involved in pathogenesis against mammalian
cells, though its mechanism remains undetermined. We also
attempted to directly test cytotoxic activity of recombinant
hexosaminidase and lysozymes produced by in vitro translation
(up to 10 mg/ml final), but failed to demonstrate it.
The serine-rich region in CPBF8 is responsible for the
binding with its cargo, but not its localization
CPBF family proteins show common structural organization:
the signal peptide at the amino terminus, the transmembrane
domain close to the carboxyl-terminal end, and the YxxL motif in
the cytosolic tail located at the carboxyl terminus (Nakada-Tsukui
K, et al., unpublished data). Besides, among 11 members, only 3
members, CPBF6, CPBF7, and CPBF8, have a stretch of serine-
rich hydrophilic region prior to the transmembrane domain
(Figure 6A and B). In order to investigate whether this region is
involved in the binding of CPBF8 to the cargos and whether the
region is involved in the phagosomal transport, we created a
transformant that expressed HA-tagged CPBF8 lacking the 23-
a.a.-long serine-rich region (CPBF8DSRR-HA). We immunopre-
cipitated CPBF8-HA and CPBF8DSRR-HA using anti-HA
antibody from lysates of the corresponding strains. Both the
silver-stained SDS-PAGE gel and immunoblot analysis with HA
antibody showed that the size of CPBF8DSRR-HA (,100 kDa)
detected was ,50 kDa smaller than that of CPBF8-HA
(,150 kDa), which was larger than predicted (Figure 6 E and F,
see below ‘‘The nature of post-translational modifications of CPBF8’’).
The amount of the 75- and 25-kDa proteins, which correspond to
b-hexosaminidase a-subunit and lysozymes, respectively, detected
in the immunoprecipitated samples from the lysates of
CPBF8DSRR-HA significantly decreased, compared to that from
CPBF8-HA strain (Figure 6E and F). The identity of the
precipitated proteins was confirmed by the immunoblots using
anti-b-hexosaminidase a-subunit antibody and lysozyme 2 anti-
body (Figure 6F).
Figure 3. Specific repression of CPBF8 gene in CPBF8gs strain.
(A) RT-PCR analysis. A 200 bp long partial CPBF8 gene was amplified
using cDNA from control and CPBF8gs strains. (B) DNA microarray
analysis of CPBF genes (CPBF1-11). The raw fluorescence data of
triplicates is shown.
doi:10.1371/journal.ppat.1002539.g003
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PLoS Pathogens | www.plospathogens.org 5 February 2012 | Volume 8 | Issue 2 | e1002539Figure 4. Enzymatic activities in total lysates, culture supernatant, and phagosomes and immuno blot analysis of total lysates and
phagosomes derived from control and CPBF8gs strains. After the amoebas were incubated in fresh medium for 2 h, trophozoites and culture
supernatant were separated by brief centrifugation. After the supernatant was removed (‘‘sup’’), the cell pellet was resuspended and solublized in
lysis buffer (‘‘ppt’’). To isolate phagosomes (E), the amoebas were incubated with latex beads, and, after brief centrifugation, the cell pellet was
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cargo binding, we constructed the variant forms of CPBF8 in
which one of two stretches of three serines in the SRR were
replaced by alanines (CPBF8AAA1-HA and CPBF8AAA2-HA,
respectively) (Figure 6C). CPBF8AAA1-HA showed reduced
ability to bind b-hexosaminidase a-subunit and lysozyme 2,
compared to CPBF8-HA and CPBF8AAA2-HA (Figure 6E and
F). These data indicate that the region containing the first stretch
of three serine residues is essential for the binding with the cargos.
Furthermore, silver staining and immunoblots with anti-HA
antibody of the lysate from CPBF8AAA1-HA showed a
,20 kDa reduction in the apparent molecular size of
CPBF8AAA1-HA, compared to CPBF8-HA. These data were
also consistent with a premise that this portion is directly post-
translationally modified or indirectly involved in post-translational
modifications (see below). We also attempted to show direct
evidence that b-hexosaminidase a-subunit and lysozymes bind to
SRR by constructing a truncated form of CPBF8, in which the
signal peptide, SRR, the transmembrane domain, and the
cytosolic region of CPBF8 were included (designated as SRR-
HA). However, neither b-hexosaminidase a-subunit nor lysozymes
was detected by immunoprecipitation of SRR-HA (data not
shown). This indicates that the SRR per se may not be sufficient
for post-translational modifications required for cargo binding.
Immunofluorescence assay showed that the localization of
CPBF8DSRR-HA, CPBF8AAA1-HA, CPBF8 AAA2-HA, and
SRR-HA such as phagosome recruitment (Figure 6D and
Supplemental information Figure S3A–C) was indistinguishable
from that of CPBF8-HA. Therefore, SRR does not appear to be
essential to phagosome targeting.
The nature of post-translational modifications of CPBF8
The apparent molecular mass of CPBF8DSRR-HA detected with
silver staining and immunoblots with anti-HA antibody was
,50 kDa smaller than that of CPBF8-HA (Figure 6, E and F,
Figure 7). The reduction of the apparent size was larger than the
predicted decrease based on the deletion of the amino acids (23 a.a.
corresponding to 2.4 kDa for CPBF8DSRR-HA). To better
understand the nature of the post-translational modification of
CPBF8, we treated the transformant with 10 mg/ml tunicamycin,
which is an inhibitor of asparagine-linked glycan modification, for
24 h (40). However, tunicamycin treatment did not affect the
apparent mobility of immunoprecipitated CPBF8-HA on SDS-
PAGE (data not shown), despite the fact that a potential N-linked
glycosylation site is present in CPBF8 (Asn383). It was previously
shown that the major GPI-anchored surface antigen of E. histolytica
trophozoites contains O-phosphodiester-linked sugars [46]. We
examined if the post-translational modification of CPBF8 contains
O-phosphodiester-linked sugars by the treatment of immunoprecip-
itated CPBF8 with trifluoroacetic acid (TFA). SDS-PAGE and
immunoblot analyses showed that TFM treatment of immunopre-
cipitated CPBF8 reduced the apparent molecular size of CPBF8 to
,120 kDa (Figure 7), which was similar to the size of CPBF8AAA1-
HA (Figure 6, E and F), while that of CPBF8DSRR-HA remained
unchanged by TFA treatment. Altogether, CPBF8 appears to
possess O-phosphodiester linked carbohydrates via the first stretchof
serines within SRR, and this region seems to be responsible for the
binding with b-hexosaminidase a-subunit and lysozymes. It should
also be noted that the apparent size of TFA-treated CPBF8-HA and
CPBF8AAA1-HA was significantly (,20 kDa) larger than that of
CPBF8DSRR-HA. The difference between CPBF8AAA1-HA and
CPBF8DSRR-HA was apparently larger than the predicted size of
SRR (2.4 kDa), suggesting that other post-translational modifica-
tion(s) may be present in other region(s) of SRR.
Discussion
Discovery of a novel transport receptor of b-
hexosaminidase a-subunit and lysozymes
CPBF8 was first identified in phagosomes by our previous
proteome study of the purified phagosomes [12]. We have recently
rediscovered CPBF8 as a homolog of CPBF1. CPBF1 was isolated
as a potential receptor/carrier of the major virulence factor of E.
histolytica, CP5, by virtue of its binding activity to CP5 (Nakada-
Tsukui K, et al., unpublished data). CPBF8 represents a novel
hydrolase receptor for the following reasons. First, CPBF8 is the
first receptor that binds to and transport b-hexosaminidase a-
subunit and lysozymes to lysosomes/phagosomes, in the manner
that is distinct from mannose-6-phosphate receptor- and sortilin-
dependent pathway. Second, there is no CPBF8 homolog in other
organisms, and showed no sequence similarity to mannose-6-
phosphate receptors or sortilin at the primary sequence level.
Mannose-6-phosphate receptor and sortilin 1 are the membrane
receptor of cathepsin D/b-hexosaminidase [47] and prosaponin/
sphingolipid activator protein [48], respectively. Third, CPBF8 is
post-translationally modified at its unique serine-rich region, and
the modification is essential for the cargo binding.
Cellular localization of CPBF8
The two representative CPBF members, CPBF1 and CPBF8, are
localized to distinct compartments in steady state. Immunofluores-
cence assay using two markers, LysoTracker and PNT, clearly
showed distinct distribution of CPBF1 and CPBF8. CPBF8 was well
colocalized with LysoTracker and PNT (Figure 1), whereas CPBF1
was seldom localized to lysosomes or colocalized with PNT
(Nakada-Tsukui K, et al., unpublished data). The different
localization of CPBF8 and CPBF1 may be attributable to the motif
sequences at the carboxyl terminus. As mentioned above, the YxxL
motif is located at the very end of the carboxyl terminus CPBF1,
while CPBF8 ends with a stretch of YxxLA, suggesting a possibility
that different accessory molecule(s) bind to CPBF 1 and CPBF8.
When CPBF1 and CPBF8 were recruited to phagosomes, the
subdomain of the phagosomal membrane they first come in
contact with, seems to be indistinguishable. CPBF8 (Figure 1A)
and CPBF1 (Nakada-Tsukui K, et al., unpublished data) were
recruited to the basolateral portion of the ‘‘phagocytic mouth’’,
similar to the domain where phosphatidylinositol-3-phosphate is
localized [35]. The fact that CPBF8 and EhPNT colocalize in
steady state and are simultaneously transported to phagosomes
upon phagocytosis, suggests that similar trafficking pathway and
resuspended, and mechanically homogenized. The phagosomes were isolated by ultracentrifugation on a sucrose gradient. Enzymatic activities of
culture supernatant, whole lysate (A–D), and phagosomes (E) are shown. (A–D) Enzymatic activities of b-hexosaminidase activity toward MUGS (A)
and MUG (B), lysozyme activity (C), and amylase activity (D) in the cell pellet and culture supernatant. (E) Enzymatic activities of b-hexosaminidase
toward MUGS, lysozyme, and amylase in phagosomes. Data shown are the means 6 standard deviations of three independent experiments. ‘‘*’’ or
‘‘**’’ represents statistical significance at p,0.01 or p,0.05, respectively. (F) Immuno blot analysis of the cell pellet and the phagosome fraction.
Approximately 20 mg of the cell pellet and 2 mg of the phagosome fraction were electrophoresed. CPBF1 and CP5 are phagosomal proteins, while
cysteine synthase 3 (CS3) is a cytosolic marker. Abbreviations are: ppt, pellet fraction; sup, culture supernatant; phagosome, phagosome fraction.
doi:10.1371/journal.ppat.1002539.g004
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predicted strength of the membrane association (one versus 11–13
transmembrane regions, respectively). Further experiments are
necessary to identify a key factor that determines cellular
localization.
Cargo specificity and physiological function of CPBF8
Affinity immunoprecipitation of CPBF8 led us to identify b-
hexosaminidase a-subunit and lysozymes as the major cargos of
CPBF8. The cargo specificity of CPBF8 was further supported by
the dramatic reduction of their enzymatic activities in both the
Figure 5. Effects of CPBF8 repression on the digestion of C. perfringens and destruction of CHO monolayers. (A) Micrographic images of
control and CPBF8gs strains coincubated with C. perfringens. Approximately 1.5610
4 cells of the control and CPBF8gs strains were incubated with
1.5610
6 C. perfringens, pretreated with 10 mM of SYTO-59. After 4 h co-incubation, amoebas were washed and microscopically examined. Bar, 10 mm.
Arrows indicate representative round shape ‘‘deformed’’ or ‘‘damaged’’ C. perfringens. Arrowheads indicate representative rod-shaped ‘‘intact’’ C.
perfringens. (B) Quantitative analysis of rod-shaped and round C. perfringens in the control and CPBF8gs strains. Data shown are the means 6
standard deviations of 20 independent cells. (C, D) Kinetics of CHO cell destruction by the control and CPBF8gs strains. Approximately 5610
4 cells of
the control and CPBF8gs strains, untreated (C) or pretreated with 200 mM of E-64 for 2 h and washed with PBS (D), were added to a monolayer of
confluent CHO cells in 24 wells and incubated at 35uC for the indicated times. Data shown are the means 6 standard deviations of four independent
experiments. Monolayer destruction is expressed as the percentage of destroyed CHO cells. Data shown are the means 6 standard deviations of four
independent experiments.
doi:10.1371/journal.ppat.1002539.g005
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diagram of the serine-rich region and transmembrane domain in CPBF8. Numbers indicate amino acid positions from the amino terminus. The filled
or hatched box depicts the serine rich region or the transmembrane domain, respectively. (B) Comparison of the carboxyl-terminal region of CPBF
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observation is consistent with the previous finding on the mouse
fibroblast, in which knockout of a specific receptor caused decrease
in the intracellular activities of b-hexosaminidase, b-galactosidase,
and b-glucuronidase [47].
Although deletion or repression of hydrolase receptors often
causes missecretion of cargos (e.g., [47]), repression of CPBF8 gene
did not result in missecretion of b-hexosaminidase a-subunit and
lysozymes. This is also in good contrast to CPBF1, gene silencing
of which caused missecretion of CP5 (Nakada-Tsukui K, et al.,
unpublished data). The outcome of deletion or repression of a
hydrolase receptor largely varies. These data suggest that the
trafficking, processing, activation, secretion, and degradation of
cysteine proteases and b-hexosaminidase a-subunit/lysozymes
largely differ despite they use the transport receptors that belong
to the same protein family. It is likely that non- or mis-targeted b-
hexosaminidasea-subunit and lysozymes remain inactive or are
swiftly degraded by proteasomes.
Lysozymes are the well-established anti-bacterial protein, which
degrades the cell wall of Gram-positive bacteria. Thus, the
reduction of destruction of C. perfringens caused by CPBF8gs can be
directly attributable to the loss of lysozymes in phagosomes. It has
also been reported that b-hexosaminidase in Drosophila melanogaster
[49] and in murine macrophages is important to repress and
control the growth of Mycobacterium marinum [49]. Therefore, the
defect in the transport of b-hexosaminidase a-subunit to
phagosomes may also be responsible for the decrease in
degradation of C. perfringens in CPBF8gs strain.
Phagosomal transport of hydrolases via CPBF8
contributes to the cytopathic activity on mammalian
cells
We have shown that the cytopathic effects of trophozoites were
decreased by repression of CPBF8, and the reduction of the
cytopathy was not due to cysteine proteases, as the decrease in the
cytopathy caused by CPBF8 gene silencing was not cancelled by
the cysteine protease inhibitor. These results support the premise
that the enzymatic activity that decreased in CPBF8gs strain, i.e.,
b-hexosaminidase a-subunit and/or lysozymes, is responsible for
the cytopathic effect remaining after E-64 treatment. The present
study is the first to show the causal link of b-hexosaminidase a-
subunit and lysozyme with virulence in eukaryotic pathogens. In
mammals, b-hexosaminidase is known to hydrolyze GM2
(sphingomyelin) [6]. Recently, it has also been shown that b-
hexosaminidase is involved in fertilization in hamster [50]. In
addition, b-hexosaminidase from the Asian corn borer Ostrinia
furnacalis was shown to degrade chitin [51]. Phylogenetic analysis
indicated that both a and b-subunit of b-hexosaminidase from E.
histolytica belong to the same clade as insect counterparts [52]. This
clade contains two different functional b-hexosaminisases from
insects. One is involved in the alteration of the structure of N-
glycans generated in the cell, while the other plays in the chitin
degradation processes. Although it has not been demonstrated
how b-hexosaminidase is involved in the cytopathy of E. histolytica,
it is conceivable that E. histolytica b-hexosaminidase degrades
glycoconjugates of the extracellular matrix components to pass
basement membranes, as previously suggested [53]. It was
reported that lysozyme gene was poorly expressed in E. histolytica
Rahman strain, which apparently lost virulence, and non-virulent
E. dispar, compared to E. histolytica HM-1:IMSS strain [54,55].
Furthermore, lysozyme was also poorly expressed in E. histolytica
trophozoites that were treated with 5-azacytidine (5-AzaC), a
potent inhibitor of DNA methyltransferase, and showed reduced
virulence [56]. Altogether, lysozymes are involved in in vitro
cytotoxicity and in vivo virulence in E. histolytica.
The fact that CP was responsible for only 15–25% of the
cytopathic effect on CHO cells in control transformant apparently
disagreed to our previous finding [29], where 70–75% of the
cytopathic effect in the HM-1 reference strain was attributable to
CP. This is likely explained by the fact that the parental strain (G3)
of the transformants for gene silencing has uncharacterized defects
as well as lack of amoebapores.
Structural determinants of cargo binding in CPBF8
As mentioned above, the most striking difference between
non-lysosomal/phagosomal CPBF1 and lysosomal/phagosomal
CPBF8, at the primary sequence level is the serine-rich domain in
Figure 7. Post-translational modification of CPBF8. CPBF8-HA
and CPBF8DSRR-HA was immunoprecipitated with anti-HA antibody
from the lysates of CPBF8-HA and CPBF8DSRR-HA transformants,
treated (+) or untreated (2) with TFA for 10 min. The samples were
separated on SDS-PAGE and silver-stained (bottom panel), or blotted
and reacted with anti-HA (top panel) or anti-lysozyme 2 antibody
(middle panel). The apparent molecular weight (kDa) of standards are
indicated on the left.
doi:10.1371/journal.ppat.1002539.g007
proteins. Boxes indicate the putative transmembrane domain. The serine-rich region is underlined. (C) The amino acid sequences of the wild-type and
mutated serine-rich regions (SRR). Note that the entire SRR was deleted in CPBF8DSRR-HA. The first or second stretch of three serine residues within
SRR were substituted with alanines in CPBF8AAA1-HA and CPBF8AAA2-HA, respectively. (D) Localization of CPBF8DSRR-HA to phagosomes. Amoebae
were incubated with Cell Tracker Blue-stained CHO cells (blue) for 60 min, fixed, and reacted with anti-HA antibody (green). Bar, 10 mm. (E–F) Isolation
and identification of binding proteins of CPBF8-HA, CPBF8DSRR-HA, CPBF8AAA1-HA, and CPBF8AAA2-HA. Lysates of CPBF8-HA, CPBF8DSRR-HA,
CPBF8AAA1-HA, and CPBF8AAA2-HA transformants were mixed with anti-HA-antibody-conjugated agarose, washed, and eluted with HA peptide.
Immunoprecipitated samples were separated on SDS-PAGE and silver stained (The upper and lower arrow indicated that b-hexosaminidase a-subunit
and lysozymes, respectively. (E), or blotted and reacted with anti-HA, b-hexosaminidase a-subunit and lysozyme2 antibody (F).
doi:10.1371/journal.ppat.1002539.g006
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either the deletion of this region or point mutations of the serine
stretch of the serine-rich region did not affect trafficking to
phagosomes, the binding of CPBF8 to b-hexosaminidase a-subunit
and lysozymes was significantly reduced. Although we cannot
exclude the possibility that truncated CPBF8 was partially mis-
folded and thus unable to bind to its cargos, characterization of the
post-translational modifications of CPBF8 via the serine-rich
region by chemical removal of its potential O-phosphodiester-
linked glycans strongly indicates that the O- phosphodiester-linked
glycan within this region appears to be involved in cargo binding.
In summary, we have discovered and characterized the novel
membrane-associated receptor for b-hexosaminidase a-subunit
and lysozymes, CPBF8, from E. histolytica. We have demonstrated
that CPBF8 plays an important role in the degradation of ingested
bacteria in phagosomes and the cysteine protease-independent
cytopathy on mammalian cells.
Materials and Methods
Microorganisms and cultivation
Trophozoites of E. histolytica strain HM-1:IMSS Cl-6 and G3
[41] were cultured axenically at 35uCi n1 3 6100 mm screw-
capped Pyrex glass tubes or plastic culture flasks in BI-S-33
medium as previously described [57,58]. CHO cells were grown in
F-12 medium (Invitrogen, Grand Island, NY) supplemented with
10% fetal bovine serum on a 10-cm-diameter tissue culture dish
(IWAKI, Tokyo, Japan) under 5% CO2 at 37uC. Clostridium
perfringens was kindly given by Fumiya Kawahara, Nippon Institute
for Biological Science Japan.
Plasmid construction and production of E. histolytica
transformants
The protein coding region of CPBF8 gene was amplified by
PCR from cDNA using sense and antisense oligonucleotides: 59-
GCGAGATCTATGTTGGCACTCTTCGCCATC-39 and 59-
GCGAGATCTAGCTAAAGTAGCATATCCAGA-39 (BglII re-
striction sites are underlined). The amplified PCR product was
digested with BglII and ligated into BglII-digested pEhExHA [28],
to produce pEhEx-CPBF8-HA. The plasmid to produce the
mutant form of CPBF8 that lacks 23a.a.-long serine-rich region
(pEhEx-CPBF8DSRR-HA) was constructed as follows. A DNA
sequence was amplified by PCR from pEhEx-CPBF8-HA using
sense and antisense oligonucleotides: 59-CCAGTTGGATGG-
ATTGTATTTGGTGTTCTT-39 and 59-GTCATCTGGTT-
GTGGATCTTC TTTAGCATC-39. The PCR product was
treated with BKL kit (Takara, Shiga, Japan), and self-ligated to
produce pEhEx-CPBF8DSRR-HA. The resulting plasmid encodes
a mutant CPBF8 protein lacking 843–865 a.a.-region
(‘‘SSSVPPTPSSSTDDKDDDSHHST’’). Two variant forms of
CPBF8 containing point mutations, S843A, S844A, and S845A,
or S851A, S852A, and S853A, respectively (designated as
CPBF8AAA1-HA and CPBF8AAA2-HA), are constructed as
follows. DNA fragments corresponding to the portion of the
protein coding region encompassing from the amino-terminal
region to the mutated amino acids of CPBF8AAA1-HA and
CPBF8AAA2-HA were amplified by PCR from pEhEx-CPBF8-
HA, using sense and antisense oligonucleotides: 59-ACAAACA-
CATTAACAATGTTGGCACTCTTCGCC -39 and 59-TGG-
TACTGCAGCAGCGTCATCTGGTTGTGG -39 (for CPBF8-
AAA1-HA) and 59-ACAAACACATTAACAATGTTGGCAC-
TCTTCGCC -39 and 59-ATCAGTTGCAGCAGCTGGT-
GTTGGTGGTAC -39 (for CPBF8AAA2-HA), where the nucle-
otides corresponding to the mutated amino acids (serine to
alanine) are double-underlined). DNA fragments corresponding
the portion of the protein coding region encompassing the
mutated amino acids of to the carboxyl-terminal region of
CPBF8AAA1-HA and CPBF8AAA2-HA were amplified by
PCR from pEhEx-CPBF8-HA using sense and antisense oligonu-
cleotides: 59- GCTGCTGCAGTACCACCAACACCATCTTC-
39 and 59- ATCATATGGATACATAGCTAAAGTAGCAT-
ATCC -39 (for CPBF8AAA1-HA), and 59- GCTGCTGCA-
ACTGATGATAAAGATGATG -39 and 59- ATCATATGGA-
TACATAGCTAAAGTAGCATATCC-39 (for CPBF8AAA2-
HA), where the nucleotides corresponding to the mutated amino
acids (serine to alanine) are double-underlined. The two amplified
fragments were mixed and ligated to BglII-digested pEhExHA
using GENEART Seamless ligation kit (Invitrogen, San Diego,
CA, USA), to produce pEhEx-CPBF8AAA1-HA and pEhEx-
CPBF8AAA2-HA. SRR-HA, which consisted of the signal
peptide, SRR, the transmembrane domain, and the cytosolic
region of CPBF8, was constructed as follow. A DNA fragment
corresponding to the signal peptide and additional four amino
acids was amplified by PCR using sense and antisense oligonu-
cleotides: 59- ACAAACACATTAACAATGTTGGCACTCTT-
CGCC -39 and 59- AGAACATGTGTACTGTCCATACG-
CAAC -39. A DNA fragment corresponding to SRR, the trans-
membrane domain, and cytosolic region was amplified by PCR
using sense and antisense oligonucleotides: 59- CAGTACA-
CATGTTCTGATGACTCTTCTTCAGTACC -39 and 59- AT-
CATATGGATACATAGCTAAAGTAGCATATCC-39. The two
amplified fragments were mixed and ligated to BglII-digested
pEhExHA using GENEART Seamless ligation kit to produce
pEhEx-SRR-HA. The transformants that expressed CPBF8-HA,
CPBF8DSRR-HA, CPBF8AAA1-HA, CPBF8AAA2-HA, or SRR-
HA were established by transfection of the wild-type HM1:IMSS
Cl6 strain by liposome-mediated transfection as previously
described [59].
Repression of gene expression was accomplished by gene
silencing, which has recently demonstrated to be mediated by
nuclear localized antisense small RNAs with 59-polyphosphate
termini [42]. Gene silencing has been seen only in G3 strain, in
which amoebapore genes are repressed. Thus, whatever pheno-
typic changes are observed by gene silencing of additional gene of
interest, need to be compared against the control G3 strain
transformed by the mock gene silencing plasmid (pSAP2-Gunma).
Furthermore, it should be evaluated, if possible, whether the
phenotypic changes are not caused by synergistic effects with
amoebapore silencing. For gene silencing of CPBF8, b-hexosamin-
idase a-subunit, and lysozyme 1 genes, the 420-bp-long 59-end of the
protein coding region was amplified by PCR from cDNA using




TTTGATGAAATTCTAATT-39 (b-hexosaminidase a-subunit); 59-
CGCAGGCCTATGTTCGCTCTCTTTTTGTG-39 and 59-C-
GCGAGCTCACCATGGACAATACCAATAGC-39 (lysozyme 1)
(StuI and SacI restriction sites are underlined). The PCR-
amplified DNA fragment was digested with StuI and SacI, and
ligated into StuI- and SacI-digested pSAP2-gunma [60], to
produce pSAP2-CPBF8, pSAP2-HexA, and pSAP2-Lys1. The
gene-silenced strains were established by the transfection of G3
strain with the corresponding plasmids as described above.
Antibodies
CPBF8 and lysozyme 2 antibodies were raised against
recombinant histidine-tagged partial CPBF8 (a.a. 14–292) and
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and purification of recombinant proteins were described before
[40]. The expression plasmids for histidine-tagged CPBF8 (a.a.14–
292) and lysozyme 2 were introduced into BL21(DE3) competent
cells (Invitrogen). Expression of the recombinant protein was
induced with 0.1 mM isopropyl-b-thiogalactoside at 37uC for 3 h.
The histidine-tagged fusion protein was purified under denaturing
condition using Ni-NTA agarose (QIAGEN, Hiden, Germany),
according to the manufacturer’s protocol. b-hexosaminidase a-
subunit antibody was raised against mixture of the peptides
LQQQTGLQDFKVSL (a.a. 77–90) and GWSKSKEYSDIQKF
(a.a. 348–361).
Anti-HA 11MO mouse monoclonal antibody was purchased
from Berkeley Antibody (Berkeley, CA). Alexa Fluor anti-mouse
and antirabbit IgG and horseradish peroxidase (HRP)-conjugated
goat anti-mouse were purchased from Invitrogen.
Immunofluorescene assay
For the staining of lysosomes, amoebae were incubated in the
BI-S-33 medium containing LysoTracker Red DND-99 (Invitro-
gen) (1:500) at 35uC for 12 h. To visualize phagosomes, CHO cells
were pre-stained with 10 bM of CellTracker Blue (Invitrogen) in
F-12 medium supplemented with 10% fetal bovine serum at 37uC
for 3 h. Labeled CHO cells were washed with phosphate-buffered
saline (PBS), and added to 8-mm wells containing E. histolytica
trophozoites on a slide glass (8 well 8 mm standard slide glass,
Thermo Scientific, Rockford, IL) and further incubated at 35uC
for 10–60 minutes. After the incubation, cells were fixed with
3.7% paraformaldehyde for 10 min, and permeabilized with 0.2%
saponin/PBS for 10 min at ambient temperature. The cells were
then reacted with anti-HA 11MO mouse monoclonal antibody
(diluted at 1:1000) and Alexa Fluor-488 antimouse secondary
antibody (1:1000). The samples were examined on a Carl-Zeiss
LSM510 conforcal laser-scanning microscope (Thornwood, NY).
Images were further analyzed using LSM510 software. We defined
CPBF8-HA- and LysoTracker-positive and negative vacuoles/
vesicles as follows: 1) we measured and averaged the signal
intensity (per pixel) of the whole intracellular area of a cell, and
also five randomly-chosen areas outside the cell to obtain a
background fluorescence level; 2) for individual vacuoles/vesicles
that had continuous fluorescent signal lining the membrane, two
straight lines were drawn, which make a right (90-degree) angle,
and a projected fluorescence histogram was obtained for each line;
3) if the peak intensity of the point on the membrane of the
vacuole/vesicle was .2 fold of the background fluorescence level,
the vesicle/vacuole was defined as ‘‘signal positive’’. The
LysoTracker-positive vacuoles/vesicle was defined similarly,
except that 1) the fluorescence of not a point on the membrane,
but a whole intravesicular/vacuolar area was measured and
averaged; and 2) the threshold of the average peak intensity of the




6 cells of CPBF8-HA-expressing amoebae
were lysed in 2 ml of lysis buffer [50 mM Tris-HCl, pH 7.5,
150 mM NaCl, 1% Triton X-100 (Tokyo Kasei, Tokyo, Japan),
0.5 mg/ml E-64 (Sigma-Aldrich, St. Louis, MO)], and suitable
amount of Complete mini mix (Roche, Barsel, Switzerland), and
was incubated with protein G-Sepharose beads (50 ml of a 80%
slurry) (Amersham Biosciences, Uppsala, Sweden) at 4uC for
90 min, centrifuged at 8006ga t4 uC for 3 min to remove proteins
that bind to the protein G-Sepharose beads non-specifically. The
precleaned lysate was mixed with 90 ml of anti-HA-conjugated
agarose (50% slurry-, Sigma-Aldrich), and incubated at 4uC for
3.5 h. The agarose beads were collected by centrifugation at 8006
ga t4 uC for 3 min, and washed four times using wash buffer
(50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% Triton-X 100).
The agarose beads were then incubated with 180 ml of HA peptide
(20 mg/ml) at 4uC for overnight to dissociate proteins from the
beads. The eluate was applied to SDS-PAGE and silver staining as
previously described [61].
Protein digestion, LC–MS, and MS/MS
Silver stained gels were excised, destained, and tryptic-digested
using modified trypsin (Applied Biosystems Darmstadt, Germany).
Briefly, excised gels were transferred to a siliconized tube,
dehydrated in acetonitrile, rehydrated in 30 mlo f1 0 m M
dithiothreitol in 0.1 M ammonium bicarbonate and reduced at
room temperature for 30 min. The sample was then alkylated in
30 ml of 50 mM iodoacetamide in 0.1 M ammonomium bicar-
bonate at room temperature for 30 min. The reagent was
removed and the sample was dehydrated in 100 ml acetonitrile,
rehydrated in 100 ml of 0.1 M ammonium bicarbonate, and then
dehydrated again in 100 ml acetonitrile and completely dried by
vacuum centrifugation. Samples were then rehydrated in 20 ng/
ml trypsin in 50 mM ammonium bicarbonate on ice for 10 min.
Any excess trypsin solution was removed and 20 mlo f5 0m M
bicarbonate added. The samples were digested overnight at 37uC
and resultant peptides were extracted in two 30 ml aliquots of 50%
acetonitrile/5% formic acid. The tryptic peptides were eluted from
the gel and then desalted by Ziptip. The resulting peptide mixture
was separated by reverse phase chromatography (DiNa nano LC
system; KYA Tech, Tokyo, Japan) using a 0.15 mm650 mm ID
HiQ sul C18W3 column (KYA Tech) and elution with 0.1%
formic acid/2% CH3CN (solvent A) and 0.1% formic acid/80%
CH3CN (solvent B) using a program 0% solvent B for 15 min,
gradient at 4%/min for 2 min, gradient at 0.86%/min for 43 min,
11%/min for 5 min, 100% solvent B for 10 min with a total flow
rate of 300 nl/min. The eluting peptides were ionized by
electrospray ionization and analyzed by a 3200 Q TRAP LC/
MS/MS System (Applied Biosystems). Peptide MS/MS spectra
were acquired in an information-dependent manner using the
Analyst QS software 2.0 acquisition features (Smart Exit, rolling
collision energy, and dynamic exclusion).
Database search
Peptide sequence data obtained by mass spectrometry were
analyzed against the E. histolytica genome database at The Institute
for Genomic Research (TIGR) (http://www.tigr.org/tdb/e2k1/
eha1/) using the Sequest algorithm. Sequencing data were also
analyzed against the non-redundant database at the National
Center of Biotechnology Information (NCBI). Individual predicted
protein sequences were manually analyzed by BLAST search
(http://www.ncbi.nlm.nih.gov/BLAST/) against the non-redun-
dant database at NCBI. The identification of the protein was
considered significant when at least two non-overlapping peptides
of a protein were detected with the probability score .95%. The
identified proteins were classified using the annotations provided
in the TIGR and NCBI database and results of BLAST search.
RT-PCR
Total RNA was extracted using TRIzol reagent (Invitrogen)
according to the manufacturer’s instructions. The synthesis of
cDNA was performed using the SuperScript III First Strand
Synthesis System (Invitrogen) according to the manufacturer’s
instructions. The cDNA synthesis was completed on a DNA
Engine Peltier Thermal Cycle (Bio-Rad Laboratories, Inc.,
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(Invitrogen) to exclude genomic DNA. PCR was performed with
the resulting cDNA as a template and specific oligonucleotide
primers. Primers used were 59 (-CAAGTGCTTCAAGTACT-
CAACCATC-39and 59-ACCATTGTTACTTCTCTTTTTAC-
GA-39 (CPBF6); 59-ATTTTATATGAACTCTCCAGACGAT-39
and 59-TAATAGTAATAATCAGCACAATAAC-39 (CPBF7). 59-
AGAAGGTTTTGTCGATGTTCAATTC-39 and 59-TAACA-
CATCCAGCAAGAATACCAGC-39 (CPBF8). PCR reaction
mixture contains 0.2 U of high-fidelity DNA polymerase (Phusion,
FINNZYME, Espoo, Finland), 56Phusion buffer, 0.16 mmol/L of
each dNTPs, 0.5 mM Primers. Parameters for PCR were: an initial
step of denaturation at 98uC for 30 sec, 25 cycles of amplification
(at 98uC for 5 sec, 53uC for 20 sec, and 72uC for 2 min), and a
final extension at 72uC for 5 min.
Microarray analysis
Expression analysis was performed using a custom E. histolytica
array from Affymetrix, Inc. (Santa Clara, CA, USA), as previously
described [62]. Labeled cRNA for hybridization was prepared
from 5 mg of total RNA according to published Affymetrix
protocol. Hybridization and scanning were performed according
to Affymetrix protocols.
Preparation of cell lysates and culture supernatants
A semi-confluent culture was harvested at 48–72 h after
initiation of the culture and resuspended in modified Opti-MEM
(Invitrogen), Opti-MEM supplemented with 1 mg/ml ascorbic
acid and 5 mg/ml cysteine. Approximately 4610
5 amoebae in
1 ml of the medium were seeded to wells of a 12-well plate. After
the culture was incubated at 35.5uC for 2 h, the culture
supernatant was centrifuged at 4006 g for 5 min at 4uCt o
remove debris. The plates were chilled on ice for 5 min and
detached trophozoites were collected.
Phagosome purification
Approximately 3–5610
6 trophozoites (per flask) were cultured
in 25-cm
2 flasks for 48 h, and washed gently with warm modified
Opti-MEM. Approximately 10
7 carboxylate-modified latex beads
(Polyscience, Warrington, PA) were added to the flasks, and the
flasks were centrifuged at 1906g for 5 min to bring the beads into
contact with the trophozoites. After centrifugation, the flasks were
placed on ice for 10 min. The trophozoites were washed three
times with cold PBS containing 20% sucrose, followed by
centrifugation at 1906 g for 5 min to remove uningested beads.
The cells containing latex beads were then resuspended in warm
BI-S-33 medium, further incubated at 37uC, and harvested after
120 min. Bead-containing phagosomes were purified as previously
described [12] with some modifications. Briefly, after harvesting,
the amoebae that contained latex beads were resuspended in cold
homogenization buffer (250 mM sucrose, pH 7.4, 3 mM imidaz-
ole, 10 mM cysteine protease inhibitor E-64, CompleteMini
protease inhibitor cocktail) and homogenized with a Dounce
homogenizer on ice. Phagosomes containing latex beads were then
separated by flotation on a sucrose step gradient as described [12].
All sucrose solutions were made in 3 mM imidazole, pH 7.4
containing 10 mM cysteine protease inhibitor E-64. Sucrose was
added to the homogenized lysate to 40%. 2 ml of the lysate
containing 40% sucrose, 2 ml each of 35, 25 and 10% sucrose
solutions were carefully overlaid in a 10 ml ultracentrifuge tube.
The sample was centrifuged in a swinging bucket rotor MLS-50
(Beckman, Brea, CA) at 131,0006 g at 4uC for 1 h. The
phagosome fraction was collected from the interface of the 10
and 25% sucrose solutions. The collected fraction (1 ml) was
mixed with 3 ml of 50% sucrose, and transferred to a new tube.
To the sample, 4 ml of 25% and 2 ml of 10% sucrose solutions
were overlaid, and the sample was centrifuged at 131,0006 g at
4uC for 1 h. The separated phagosome sample, collected from the
interface of the 10 and 25% sucrose solutions, was finally mixed
with the same volume of 3 mM imidazole solution and centrifuged
at 13,0006g at 4uC for 5 min. The pellet were suspended with 7%
sucrose solution and stocked in 280uC.
Enzymatic assay
b-hexosaminidase assay was performed as previously described
[43] with some modifications.Briefly,the reactionmixture consisted
of 25 mM citrate buffer, pH 4.0, 10 mM 4-methylumbelliferyl-6-
sulfo-2-acetamido-2-deoxy-b-D-glucopyranoside (MUGS)(Merck,
Darmstadt, Germany) or 4-methylumbelliferyl -2-acetamido-2-
deoxy-b-D-glucopyranoside (MUG)(Sigma) as substrates, and
amoeba cell lysates, culture supernatant or phagosome fraction.
The reaction was initiated by addition of the substrates and stopped
by addition of 0.2 M glycine/0.2 M sodium carbonate, pH 10.5).
The fluorescence of the released 4-methylumbelliferone was
measured at excitation and emission wavelengths of 360 and
440 nm, respectively. The lysozyme assay was performed by
EnzChek Lysozyme Assay Kit (Invitrogen). Briefly, the reaction
mixture contained amoeba lysates, culture supernatant or phago-
somal fraction and 200 mg/ml of Bodipy-conjugated Micrococcus
lysodeikticuscell wall,andthe fluorescencewas measuredatexcitation
and emission wavelengths of 485 and 530 nm, respectively. The
amylase assay was performed by EnzChek amylase Assay Kit
(Invitrogen). Briefly, the reaction mixture contained amoebalysates,
culture supernatant or phagosomal fraction, and 200 mg/ml of
substrate solution, and the fluorescence was measured at excitation
and emission wavelengths of 485 and 530 nm.
Digestion assay of C. perfringens
Approximately 1.5610
4 trophozoites of control or CPBF8gs strain
and 1.5610
6 C. perfringens were incubated in 150 ml of BIS medium
with 10 mM SYTO-59 (Invitrogen) on glass bottom culture dish(-
Mattek, MA, USA) under anaerobic condition for 4 h. After
incubation, the cellwas washed with BIS and observed bymicroscopy
under anaerobic condition on a Carl-Zeiss LSM510 conforcal laser-
scanning microscope. The numbers of rod and round shape bacteria
are counted. Images were further analyzed using LSM510 software.
In vitro translation
The soluble region of lysozyme 1 and 2 were expressed by TN
SP6 High-Yield Wheat Germ Protein Expression System (Pro-
mega, WI, USA). The HA-tagged lysozyme 1 and 2 were
amplified by PCR from cDNA using sense and antisense
oligonucleotides: 59- GGGGCGATCGCATGTATCCATAT-
GATGTTCCAGATTATGCTAAATTAGGTATTGATGTCT-
CTC -39 and 59- GGGGTTTAAACTTATGGTTTGTAGTTA-
TAATC -39 (for HA-lysozyme 1) and 59-G GGGCGATCG-
CATGTATCCATATGATGTTCCAGATTATGCTGTAGAT-
GTATCTCAACC -39 and 59- GGGGTTTAAACTTAAAAAT-
TAAATAAAAAGAAATGAG -39 (for HA-lysozyme 2), where
PmeI and SgfI restriction sites are underlined and the sequence
corresponding to the HA-tag are double underlined, respectively.
The PCR-amplified DNA fragments were digested with PmeI and
SgfI, and ligated into PmeI- and SgfI-digested pF3A WG (BYDV)
Flexi vector, to produce pF3A-HA-lysozyme 1 and 2. Expression
of HA-lysozyme 1 and 2 was performed according to the
manufacturer’s protocol. The reactions were done at 25uC for
2 h. The purification of HA-lysozyme 1 and 2 was performed as
described above for immunoprecipitation.
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CHO monolayer destruction was measured as described
previously with minor modifications [63]. Briefly, CHO cells were
grown with confluent in 24 well plate for over-night.at 37uC and
5% CO2.The medium was removed and the plates were washed
with modified Opti-MEM medium. Approximately 5610
4
trophozoites of control or CPBF8gs strains were resuspended in
0.5 ml of modified Opti-MEM medium and added to each well.
The plates were incubated under anaerobic conditions at 35.5uC
for up to 3 h. The plates were placed on ice for 10 min to detach
trophozoites. The number of CHO cells remaining in the wells
was measured by WST-1 reagent (Roche) as described previously
[64]. The cytopathic activity of recombinant HA-lysozyme 1 and 2
toward mammalian cells was evaluated by incubating confluent
CHO cells with the mixture of purified recombinant proteins and
10% FBS/F-12 (1:99) on a 24 well plate. The plates were
incubated at 35.5uC for 24 h. The number of CHO cells
remaining in the wells was estimated by WST-1 reagent.
Accession numbers
CPBF1, EHI_164800, XP_655218; CPBF2, EHI_087660,
XP_653276; CPBF3, EHI_161650, XP_649180; CPBF4,
EHI_012340, XP_655897; CPBF5, EHI_137940, XP_654065;
CPBF6, EHI_178470, XP_653036; CPBF7, EHI_040440,
XP_649361; CPBF8, EHI_059830, XP_652899; CPBF9,
EHI_021220, XP_655360; CPBF10, EHI_191730, XP_649015;
CPBF11, EHI_118120, XP_656044; b-hexosaminidase a-subunit,
EHI_148130, XP_657529; Lysozyme 1, EHI_199110, XP_
653294; Lysozyme 2, EHI_096570, XP_656933
Supporting Information
Figure S1 Growth kinetics of control and CPBF8gs strains.
Approximately five thousands amoebae were inoculated to 6-ml
culture medium. The amoebae of each strain were counted every
24 hours. Data shown are the means 6 standard deviations of five
biological replicates.
(TIF)
Figure S2 Confirmation of gene silencing in b-hexosaminidase
a-subunit (HexAgs) and lysozyme 1 (Lys1gs) gene-silenced strains
and their ability for the destruction of CHO monolayers. (A)
Reverse transcriptase-PCR analysis. A 420-bp long partial HexA,
Lys1, and Lys2 genes were amplified using cDNA from control,
HexAgs, and Lys1gs strains. Abbreviations are: HexA, b-
hexosaminidase a-subunit; Lys1, lysozyme 1; gs, gene-silenced.
(B) The kinetics of CHO cell destruction by control, HexAgs, and
Lys1gs strains. Approximately 5610
4 cells of the control and
HexAgs and Lys1gs strains were added to a monolayer of
confluent CHO cells in a well of a 24-well plate and incubated at
35uC for the indicated times. Monolayer destruction is expressed
as the percentage of destroyed CHO cells.
(TIF)
Figure S3 Localization of CPBF8AAA1-HA, CPBF8AAA2-HA,
and SRR-HA to phagosomes. Trophozoites of CPBF8AAA1-HA
(A), CPBF8AAA2-HA (B), and SRR-HA (C) were incubated with
CellTracker Blue-stained CHO cells (blue) for 60 min, fixed, and
reacted with anti-HA antibody (green). Bar, 10 mm.
(TIF)
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